This inventor holds 6 USPTO granted patents. Top assignees: Columbia University, Pioneer Hi-Bred International, Inc., Other. Active years: 1999-2016.
Company Filing History:


Years Active: 1999-2016
Title: The Innovative Contributions of Rodney J Rothstein
Introduction
Rodney J Rothstein is a notable inventor based in Maplewood, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 6 patents, Rothstein's work focuses on methods to combat cancer and the underlying biological mechanisms involved.
Latest Patents
Rothstein's latest patents include groundbreaking methods to treat cancer using cyclosporine and cyclosporine derivatives. He has also developed methods to treat certain types of cancer with cyclophilin inhibitors. Another significant invention involves a small protein that interacts with a ribonucleotide reductase subunit. This invention provides an isolated Sml1 protein or a homologue thereof, along with a screening assay for identifying compounds that can reduce the division rate of a cell by altering the interaction between ribonucleotide reductase and the Sml1 protein.
Career Highlights
Throughout his career, Rothstein has worked with prestigious institutions, including Columbia University and Pioneer Hi-Bred International, Inc. His research has contributed to advancements in cancer treatment and has the potential to improve patient outcomes significantly.
Collaborations
Rothstein has collaborated with notable colleagues such as Bruce J Drummond and Benjamin A Bowen. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to impactful discoveries.
Conclusion
Rodney J Rothstein's contributions to cancer research and treatment exemplify the power of innovation in addressing critical health challenges. His patents and collaborations reflect a commitment to advancing scientific knowledge and improving therapeutic options for patients.